Has Brianna Bowdren received payments from drug or device companies?

Yes. Drug and device makers reported $6,188 in general payments to Brianna Bowdren across 317 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brianna Bowdren did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brianna Bowdren come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brianna Bowdren

Psychiatric/Mental Health · Syracuse, NYNPI 1720762289

Payments from drug & device makers

$6,188in general payments, 2019–2025

Across 317 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Teva Pharmaceuticals USA, Inc.$860
Alkermes, Inc.$590
Neurocrine Biosciences, Inc.$503
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$402
Vanda Pharmaceuticals Inc.$388
plus $2K from 14 others

What the payments were for

Food & beverage$6,180100%
Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	49	$1,081
Teva Pharmaceuticals USA, Inc.	49	$860
Alkermes, Inc.	32	$590
Neurocrine Biosciences, Inc.	32	$503
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	23	$402
Vanda Pharmaceuticals Inc.	16	$388
Lundbeck LLC	16	$362
E.r. Squibb & Sons, L.L.C.	14	$325
Johnson & Johnson	13	$309
Axsome Therapeutics, Inc.	14	$284
Takeda Pharmaceuticals U.S.A., Inc.	13	$230
Otsuka America Pharmaceutical, Inc.	11	$224
Almatica Pharma LLC	9	$192
Indivior Inc.	7	$159
Corium, LLC	8	$72
Bausch Health US, LLC	3	$65
Biogen	3	$50
Braeburn Inc.	2	$40
Luye Pharma (USA) Ltd.	2	$36
Collegium Pharmaceutical, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,188 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Austedo XrDeutetrabenazine	40	$281,086
Invega SustennaPaliperidone Palmitate	46	$158,074
RexultiBrexpiprazole	35	$67,598
SpravatoEsketamine Hcl	18	$41,131
LybalviOlanzapine/Samidorphan Malate	22	$33,747
VraylarCariprazine Hcl	22	$31,868
TrintellixVortioxetine Hydrobromide	43	$23,148
Paliperidone ErPaliperidone	50	$21,109
SunosiSolriamfetol Hcl	11	$13,651
Bupropion XlBupropion Hcl	271	$7,053
AdderallDextroamphetamine/Amphetamine	11	$6,427
VyvanseLisdexamfetamine Dimesylate	14	$4,335
Adderall XrDextroamphetamine/Amphetamine	11	$4,270
Modafinil	79	$4,225
Clonazepam	379	$3,915

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr	$860	$281,08640 claims
Johnson & JohnsonInvega Sustenna, Spravato	$309	$199,20564 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$224	$67,59835 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Adderall, Vyvanse	$230	$33,91068 claims
Alkermes, Inc.Lybalvi	$590	$33,74722 claims
AbbVieVraylar	$1,081	$31,86822 claims
Axsome Therapeutics, Inc.Sunosi	$284	$13,65111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Syracuse

Sherie RamsgardSyracuse$52K
Laneasha EudellSyracuse$15K
Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →